Detailed information for compound 812071

Basic information

Technical information
  • TDR Targets ID: 812071
  • Name: 3-nitro-N-phenylaniline
  • MW: 214.22 | Formula: C12H10N2O2
  • H donors: 1 H acceptors: 2 LogP: 3.29 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: [O-][N+](=O)c1cccc(c1)Nc1ccccc1
  • InChi: 1S/C12H10N2O2/c15-14(16)12-8-4-7-11(9-12)13-10-5-2-1-3-6-10/h1-9,13H
  • InChiKey: VNRHTFXMONFRSL-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 3-nitro-N-phenyl-aniline
  • (3-nitrophenyl)-phenyl-amine
  • 4531-79-7
  • Benzenamine, 3-nitro-N-phenyl-
  • Diphenylamine, 3-nitro-
  • 3-NITRO-N-PHENYLBENZENAMINE
  • 3-Nitrodiphenylamine
  • EC-000.1472
  • ZINC03878704
  • CBMicro_014246
  • Oprea1_294008
  • BIM-0014165.P001

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0008 0.0088 0.0088
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0037 0.1905 1
Echinococcus multilocularis hyperpolarization activated cyclic 0.0008 0.0088 0.0088
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0008 0.0088 0.0463
Treponema pallidum hypothetical protein 0.0006 0 0.5
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0008 0.0088 0.0088
Trypanosoma brucei membrane transporter protein, putative 0.0073 0.4165 1
Echinococcus multilocularis hyperpolarization activated cyclic 0.0008 0.0088 0.0088
Schistosoma mansoni voltage-gated potassium channel 0.0043 0.2294 0.2294
Trypanosoma cruzi hypothetical protein, conserved 0.0073 0.4165 1
Trypanosoma cruzi hypothetical protein, conserved 0.0073 0.4165 1
Echinococcus multilocularis geminin 0.0167 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0073 0.4165 1
Schistosoma mansoni multidrug resistance protein 0.0073 0.4165 0.4165
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0008 0.0088 0.0463
Echinococcus multilocularis voltage gated potassium channel 0.0012 0.0315 0.0315
Giardia lamblia Na+ driven multidrug efflux pump 0.0006 0 0.5
Schistosoma mansoni hypothetical protein 0.0167 1 1
Trypanosoma brucei membrane transporter protein, putative 0.0073 0.4165 1
Echinococcus granulosus potassium voltage gated channel subfamily H 0.004 0.2067 0.2067
Trypanosoma cruzi membrane transporter protein, putative 0.0073 0.4165 1
Schistosoma mansoni voltage-gated potassium channel 0.0043 0.2294 0.2294
Schistosoma mansoni hypothetical protein 0.0167 1 1
Trypanosoma brucei membrane transporter protein, putative 0.0073 0.4165 1
Schistosoma mansoni voltage-gated potassium channel 0.0008 0.0088 0.0088
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.0012 0.0315 0.0315
Echinococcus multilocularis potassium voltage gated channel subfamily H 0.004 0.2067 0.2067
Trichomonas vaginalis voltage and ligand gated potassium channel, putative 0.0037 0.1905 1
Schistosoma mansoni voltage-gated potassium channel 0.0012 0.0315 0.0315
Echinococcus multilocularis potassium:sodium hyperpolarization activated 0.0008 0.0088 0.0088
Loa Loa (eye worm) hypothetical protein 0.0034 0.1742 0.8354
Echinococcus granulosus cyclic nucleotide gated cation channel alpha 3 0.0008 0.0088 0.0088
Plasmodium falciparum multidrug efflux pump, putative 0.0006 0 0.5
Giardia lamblia Na+ driven multidrug efflux pump 0.0006 0 0.5
Echinococcus multilocularis cyclic nucleotide gated cation channel 0.0008 0.0088 0.0088
Schistosoma mansoni hyperpolarization activated cyclic nucleotide-gated potassium channel 0.0008 0.0088 0.0088
Echinococcus granulosus multidrug and toxin extrusion protein 2 0.0073 0.4165 0.4165
Schistosoma mansoni voltage-gated potassium channel 0.0012 0.0315 0.0315
Echinococcus granulosus hyperpolarization activated cyclic 0.0008 0.0088 0.0088
Brugia malayi Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog 0.0012 0.0315 0.1145
Loa Loa (eye worm) hypothetical protein 0.0012 0.0315 0.1145
Echinococcus granulosus voltage gated potassium channel 0.0012 0.0315 0.0315
Trypanosoma brucei MATE efflux family protein, putative 0.0073 0.4165 1
Mycobacterium ulcerans DNA-damage-inducible protein F DinF 0.0006 0 0.5
Echinococcus granulosus potassium voltage gated channel subfamily H 0.0012 0.0315 0.0315
Trypanosoma cruzi hypothetical protein, conserved 0.0073 0.4165 1
Loa Loa (eye worm) voltage and ligand gated potassium channel 0.004 0.2067 1
Leishmania major hypothetical protein, conserved 0.0073 0.4165 1
Echinococcus granulosus cyclic nucleotide gated cation channel 0.0008 0.0088 0.0088
Echinococcus multilocularis Multi antimicrobial extrusion protein MatE 0.0067 0.3765 0.3765
Echinococcus granulosus hyperpolarization activated cyclic 0.0008 0.0088 0.0088
Trypanosoma cruzi hypothetical protein, conserved 0.0073 0.4165 1
Schistosoma mansoni cyclic-nucleotide-gated cation channel 0.0008 0.0088 0.0088
Brugia malayi Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog 0.004 0.2067 1
Giardia lamblia Na+ driven multidrug efflux pump 0.0006 0 0.5
Leishmania major hypothetical protein, conserved 0.0073 0.4165 1
Echinococcus multilocularis cyclic nucleotide gated cation channel alpha 3 0.0008 0.0088 0.0088
Echinococcus granulosus cyclic nucleotide gated cation channel 0.0008 0.0088 0.0088
Schistosoma mansoni hyperpolarization activated cyclic nucleotide-gated potassium channel 0.0008 0.0088 0.0088
Echinococcus granulosus potassium:sodium hyperpolarization activated 0.0008 0.0088 0.0088
Echinococcus multilocularis multidrug and toxin extrusion protein 2 0.0073 0.4165 0.4165

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.